AdvanCell Establishes U.S. Global Headquarters and Secures Flagship Manufacturing Facility in Greater Boston to Drive Growth Strategy

▤ Summary

AdvanCell is setting up its U.S. global headquarters in Greater Boston and leasing a 128,000-square-foot facility in Andover. The site will serve as the company’s first internal U.S. manufacturing center and support development and future commercialization of ADVC001 and its Lead-212 pipeline. The company will also work with a CDMO to add drug product manufacturing capacity while it completes fit-out and qualification of the new site. This expansion strengthens AdvanCell’s vertically integrated radiopharmaceutical platform across the U.S. and Australia.

▦ Linked Companies